MTUSD:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF USD Capitalisation (USD)

ETF | Others |

Last Closing

USD 9.7092

Change

-0.04 (-0.44)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.01 (+0.02%)

USD 67.33B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.60 (+0.12%)

USD 11.54B
WRD:PA HSBC ETFs Public Limited Compa..

+0.10 (+0.31%)

USD 9.41B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.64 (+0.69%)

USD 7.83B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.45 (+0.54%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.07 (+0.14%)

USD 7.02B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.03 (+0.31%)

USD 6.60B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.31%)

USD 5.52B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.65 (+0.18%)

USD 4.87B
500U:PA Amundi Index Solutions - Amund..

+0.77 (+0.72%)

USD 4.29B

ETFs Containing MTUSD:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.43% 13% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.43% 12% F 37% F
Trailing 12 Months  
Capital Gain -0.33% 16% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.33% 15% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike